what is a glp-1 agonist Current Insights, Advantages and Challenges of Small Molecule Glucagon-like Peptide 1 Receptor Agonists: Scoping Review GLP-1 Medications for Weight Loss:
Description
van EenigeRYingZTramperNWiebingVSirajZde BoerJFet alCombined glucose-dependent insulinotropic polypeptide receptor and glucagon-like peptide-1 receptor agonism attenuates atherosclerosis severity in APOE*3-Leiden.CETP mice
Moreover, for adults with type 2 diabetes or prediabetes and nonalcoholic fatty liver disease (NAFLD), the ADA suggests considering GLP-1 receptor agonists or dual GIP/GLP-1 receptor agonists as part of the treatment plan
Front Immunol 2016
Across age groups, current GLP-1 use is highest among adults ages 50-64 (22%)
Affectionately called 'Lizzie, or Gilly' by diabetic patients and marketed as 'Byetta', exenatide was the first slow-release GLP-1 mimic to reach the market (Schuler, Shearin)
Use Zepbound 1 time each week, at any time of the day
